Literature DB >> 23414827

Renal scintigraphy in the acute care setting.

Efrosyni Sfakianaki1, George N Sfakianakis, Mike Georgiou, Bernard Hsiao.   

Abstract

Renal scintigraphy is a powerful imaging method that provides both functional and anatomic information, which is particularly useful in the acute care setting. In our institution, for the past 2 decades, we have used a 25-minute renal diuretic protocol, technetium-99m ((99m)Tc) mercaptoacetyltriglycine with simultaneous intravenous injection of furosemide, for all ages and indications, including both native and transplant kidneys. As such, this protocol has been widely used in the workup of acutely ill patients. In this setting, there are common clinical entities which affect patients with native and transplant kidneys. In adult patients with native kidneys one of the most frequent reasons for emergency room visits is renal colic due to urolithiasis. Although unenhanced computed tomography is useful to assess the anatomy in cases of renal colic, it does not provide functional information. Time zero furosemide renal scintigraphy can do both and we have shown that it can effectively stratify patients with renal colic. To this end, 4 characteristic patterns of scintirenography have been identified, standardized, and consistently applied: no obstruction, partial obstruction (mild vs high grade), complete obstruction, and stunned (postdecompressed) kidney. With the extensive use of this protocol over the past 2 decades, a pattern of "regional parenchymal dysfunction" indicative of acute pyelonephritis has also been delineated. This information has proved to be useful for patients presenting with urinary tract infection and suspected pyelonephritis, as well as for patients who were referred for workup of renal colic but were found to have acute pyelonephritis instead. In instances of abdominal trauma, renal scintigraphy is uniquely suited to identify urine leaks. This is also true in cases of suspected leak following renal transplant or from other iatrogenic/postsurgical causes. Patients presenting with acute renal failure can be evaluated with renal scintigraphy. A scintigraphic pattern of "relative preservation of flow as compared to function" has been identified as indicative of acute tubular necrosis, which is distinct from other potential causes of acute renal failure, such as nephrotoxicity and in the case of renal transplants, rejection.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23414827     DOI: 10.1053/j.semnuclmed.2013.01.001

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  5 in total

1.  SNMMI Procedure Standard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults With Suspected Upper Urinary Tract Obstruction 1.0.

Authors:  Andrew T Taylor; David C Brandon; Diego de Palma; M Donald Blaufox; Emmanuel Durand; Belkis Erbas; Sandra F Grant; Andrew J W Hilson; Anni Morsing
Journal:  Semin Nucl Med       Date:  2018-03-16       Impact factor: 4.446

Review 2.  Nuclear medicine and the emergency department patient: an illustrative case-based approach.

Authors:  Fatemeh Behnia; Joel A Gross; Monica Ragucci; Serena Monti; Marcello Mancini; Shana Elman; Hubert Vesselle; Lorenzo Mannelli
Journal:  Radiol Med       Date:  2014-08-13       Impact factor: 3.469

Review 3.  Imaging-based diagnosis of acute renal allograft rejection.

Authors:  Gerold Thölking; Katharina Schuette-Nuetgen; Dominik Kentrup; Helga Pawelski; Stefan Reuter
Journal:  World J Transplant       Date:  2016-03-24

Review 4.  Radionuclides in nephrourology, Part 2: pitfalls and diagnostic applications.

Authors:  Andrew T Taylor
Journal:  J Nucl Med       Date:  2014-03-03       Impact factor: 10.057

5.  Acute urinary obstruction during 99mTc-ethylenedicysteine diuretic renal scintigraphy acquisition: Is furosemide the culprit?

Authors:  Shelvin Kumar Vadi; Anish Bhattacharya; Ashwani Sood; Bhagwant Rai Mittal
Journal:  World J Nucl Med       Date:  2020-01-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.